[Source: Research & Innovation] An EU- and industry-funded project has identified potential biomarkers that could indicate how likely a drug is to cause cancer at an earlier stage of testing than is currently possible, which could save drug companies time and money - and lead to safer drugs reaching patients faster.
from EUROPA - Syndicated Research News Feed https://ift.tt/2sIbz41
via IFTTT
No comments:
Post a Comment